Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)
A Prospective Multi-center Clinical Study to Evaluate the Safety and Effectiveness of the Light Adjustable Lens (LAL) in Subjects Undergoing Cataract Extraction
Sponsor: Calhoun Vision, Inc.
This NA trial investigates Cataracts and is currently completed. Calhoun Vision, Inc. leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Aug 2018 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
Status: Withheld → Completed
-
Feb 2017 — Dec 2017 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Calhoun Vision, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .